
Ellipsis Health
Founded Year
2017Stage
Series A - II | AliveTotal Raised
$49.39MLast Raised
$19M | 5 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+174 points in the past 30 days
About Ellipsis Health
Ellipsis Health provides health case management solutions using machine learning within the healthcare sector. It was founded in 2017 and is based in San Francisco, California.
Loading...
Ellipsis Health's Product Videos
ESPs containing Ellipsis Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The mental health voice biomarkers market offers solutions to diagnose mental issues by monitoring changes in speech patterns. These companies use machine learning to analyze vocal patterns to detect changes in a person’s mood, emotion, and mental state over time, providing clinicians with data for more precise and accurate diagnoses. The market also aims to improve patient outcomes, reduce health…
Ellipsis Health named as Highflier among 9 other companies, including Sonde Health, Canary Speech, and Kintsugi.
Loading...
Research containing Ellipsis Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Ellipsis Health in 4 CB Insights research briefs, most recently on Oct 23, 2025.


Oct 20, 2025 report
Digital Health 50: The most promising digital health startups of 2025
Sep 13, 2023
The mental health tech market mapExpert Collections containing Ellipsis Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ellipsis Health is included in 8 Expert Collections, including Digital Health.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,123 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Digital Health 50
200 items
2022's cohort of the most promising digital health startups transforming the healthcare industry. Winners were chosen based on several factors, including data submitted by the companies, proprietary Mosaic scores, company business models and momentum in the market.
Mental Health Tech
791 items
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Artificial Intelligence (AI)
20,629 items
Ellipsis Health Patents
Ellipsis Health has filed 11 patents.
The 3 most popular patent topics include:
- psychiatric diagnosis
- computational linguistics
- mood disorders

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/1/2024 | 2/18/2025 | Natural language processing, Psychiatric diagnosis, Computational linguistics, Abnormal psychology, Mood disorders | Grant |
Application Date | 2/1/2024 |
|---|---|
Grant Date | 2/18/2025 |
Title | |
Related Topics | Natural language processing, Psychiatric diagnosis, Computational linguistics, Abnormal psychology, Mood disorders |
Status | Grant |
Latest Ellipsis Health News
Oct 17, 2025
| MarketsandMarkets™ News provided by Share this article Share toX DELRAY BEACH, Fla., Oct. 17, 2025 /PRNewswire/ -- The global Patient Experience Technology Market , valued at US$0.59 billion in 2024, stood at US$0.66 billion in 2025 and is projected to advance at a resilient CAGR of 11.8% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. Growing emphasis on value-based care, regulatory mandates for patient experience, and the integration of AI and analytics to streamline clinical workflows are key factors driving the growth of the patient experience technology market. Browse in-depth TOC on " Patient Experience Technology Market " 150 - Tables 350 - Pages By offerings, the patient experience technology market is segmented into software and services. The software segment is expected to dominate the patient experience technology market during the forecast period. The growth is driven by the increasing adoption of digital tools that enhance patient engagement and streamline healthcare operations. This segment includes on-premise, cloud-based, and hybrid models, offering flexibility and scalability to healthcare organizations. Growth is further supported by the integration of AI, analytics, and interoperability features that enable real-time insights, personalized patient experiences, and seamless coordination across multiple care touchpoints. By end user, the patient experience technology market is segmented into healthcare providers, healthcare payers, pharma & biotech companies, and other end users. The healthcare payers segment is projected to register a significant CAGR during the forecast period, supported by the growing need for improved patient communication, claims management, and personalized engagement solutions to enhance member satisfaction and operational efficiency. Additionally, payers are increasingly leveraging digital platforms to reduce administrative costs, streamline authorization processes, and offer value-based care programs, further driving the adoption of patient experience technologies. By geography, North America holds a significant share of the patient experience (PX) technology market. The region's dominance is driven by its advanced healthcare infrastructure, high digital literacy among providers as well as patients, and substantial investments in patient-centered care solutions. Hospitals and large health systems are increasingly adopting PX platforms to enhance patient engagement, streamline operations, and improve care outcomes across the continuum of care. The ongoing shift toward value-based care models and the rising emphasis on patient satisfaction are further accelerating adoption. In July 2025, Cedars-Sinai (US) implemented an AI-powered virtual care platform, CS Connect, automating patient intake, symptom assessment, and treatment recommendations, improving access and reducing administrative burdens. Similarly, in June 2025, Ellipsis Health (US) raised USD 45 million to expand its AI-driven platform, Sage, which autonomously engages patients between appointments to support medication adherence and discharge instructions. These developments highlight that AI-powered PX technologies are reshaping care delivery by enhancing access, reducing provider workload, and ensuring continuous patient engagement beyond clinical encounters, thereby driving North America's leadership in patient experience technology adoption. As of 2024, the key players operating in the global orthopedic braces and supports market are DJO LLC (US), Ossur HF (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), Essity AB (Sweden), 3M Company (US), Zimmer Biomet (US), Ottobock Healthcare (Germany), Thuasne (France), ALCARE Co., Ltd (Japan), Nippon Sigmax (Japan), Bird & Cronin (US), and DeRoyal Industries (US) among others. Press Ganey Press Ganey is one of the major providers of patient experience measurement, performance analytics, and strategic advisory solutions for healthcare organizations. It serves over 41,000 healthcare facilities, offering comprehensive platforms for patient, employee, consumer, and member experiences, along with tools for safety, high reliability, and clinical excellence. The company's patient experience platforms, including CAHPS & Regulatory surveys, iRound, and NarrativeDX, help healthcare providers deliver personalized care, streamline patient rounding, and optimize real-time service recovery. The company provides products to more than 125,000 customers through a direct sales force, third-party distributors, and independent sales representatives. NRC Health NRC Health is a prominent provider of experience management solutions tailored for the healthcare industry. Its platform leverages artificial intelligence to collect and analyze feedback from patients, employees, and communities, offering insights to help healthcare organizations enhance service delivery and patient satisfaction. The company offers nQuire, an AI-powered tool that analyzes patient feedback to uncover hidden insights, enabling healthcare providers to make data-driven decisions to improve patient experience. The Huey AI engine assists healthcare organizations in understanding and responding to patient needs, fostering more personalized and human-centered care. The company has a comprehensive approach to experience management that encompasses patient, employee, customer, and market experiences. Medallia Inc. Medallia Inc. is one of the leading providers of experience management solutions. It offers the Medallia Experience Cloud, an AI-driven SaaS platform that unifies feedback from surveys, voice, digital interactions, and social media into actionable insights. The company operates as a private entity focused on innovation and expansion across industries, including healthcare. Its platform captures real-time patient signals, enabling hospitals to personalize care, close feedback loops, and enhance service delivery. In healthcare, it offers tools such as the Medicare Stars Solution and Ambulatory Patient Experience Suite, supporting payers and providers in improving quality scores and patient engagement. Key developments include AI-powered tools such as Ask Athena and Smart Response. Related Reports: About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets™, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. Contact:
Ellipsis Health Frequently Asked Questions (FAQ)
When was Ellipsis Health founded?
Ellipsis Health was founded in 2017.
Where is Ellipsis Health's headquarters?
Ellipsis Health's headquarters is located at 118 2nd Street, San Francisco.
What is Ellipsis Health's latest funding round?
Ellipsis Health's latest funding round is Series A - II.
How much did Ellipsis Health raise?
Ellipsis Health raised a total of $49.39M.
Who are the investors of Ellipsis Health?
Investors of Ellipsis Health include Khosla Ventures, AME Cloud Ventures, E12 Venture Capital, Mitsui & Co. Global Investment, Colliers and 33 more.
Who are Ellipsis Health's competitors?
Competitors of Ellipsis Health include Hippocratic AI, Hyro, Virtuosis AI, Slingshot AI, Commure and 7 more.
Loading...
Compare Ellipsis Health to Competitors

Kintsugi focuses on mental health care within the healthcare industry. The company offers an application programming interface (API)-first platform that uses voice biomarker technology to identify and prioritize mental health challenges, integrating with various healthcare systems to facilitate timely care. Kintsugi primarily serves the healthcare sector, providing tools for telehealth, call centers, and remote patient monitoring. It was founded in 2019 and is based in Berkeley, California.

Sonde Health specializes in health technology and focuses on voice-enabled symptom detection and monitoring within the healthcare sector. The company offers a platform that analyzes vocal features to assess mental, cognitive, and respiratory health, providing actionable insights for early detection and management of health conditions. It was founded in 2015 and is based in Boston, Massachusetts.

Thymia specializes in mental health technology, providing AI-powered assessments to objectively measure and monitor mental health conditions. The company offers tools that leverage machine learning and neuropsychology to accurately identify mental illness symptoms using a unique combination of voice, video, and behavioral data. Thymia primarily serves healthcare providers, payers, and employers with its mental health evaluation and monitoring solutions. It was founded in 2020 and is based in London, United Kingdom.

Modality.AI is a company that assesses neurological and psychiatric conditions using a multimodal platform in the clinical research sector. The company provides automated analysis of speech, facial expressions, and motor functions for clinical trials, both in-clinic and remotely, without requiring specialized equipment or personnel. Modality.AI serves the pharmaceutical and biotechnology industries by offering tools for clinical assessments. It was founded in 2018 and is based in San Francisco, California.

Deliberate AI focuses on the application of artificial intelligence in the healthcare sector, specifically in the assessment of psychiatric and neurological health. The company's main service involves the extraction of features from audio-visual signals and other modalities to compute clinically significant biomarkers and predictive models for psychiatric and neurologic disorders. Its services primarily cater to the life sciences industry, including biopharma and medical device companies. It was founded in 2020 and is based in New York, New York.

Click Therapeutics focuses on the development and commercialization of software-based prescription medical treatments within the healthcare sector. The company offers digital therapeutics and software-enhanced drugs that aim to provide clinical applications in various therapeutic areas. Click Therapeutics serves the healthcare industry, with a focus on psychiatric, neurological, oncological, cardiological, and immunological therapeutic areas. It was founded in 2012 and is based in New York, New York.
Loading...
